Back

Antiplatelet therapy and prognosis at the onset of stent thrombosis

28 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yuki Matsuoka

Osaka University Graduate School of Medicine, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
The association between the hsCRP/BMI ratio and cardiovascular prognosis in CAD patients
Doctor J. Yang (Beijing, CN)
Abstract Slides
Presentation thumbnail
In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study
Mr Y. Wang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Association of inflammatory activation with acute stent thrombosis
Doctor K. Krychtiuk (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The influence of early post-STEMI inflammation on diastolic function: diagnostic and therapeutic implications
Doctor S. Filip (Lyon, FR)
Abstract Slides Video
Presentation thumbnail
Helicobacter pylori and pro-inflammatory protein biomarkers in myocardial infarction with and without obstructive coronary artery disease
Doctor J. Warme (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
One year incidence of events after definite coronary stent thrombosis: a retrospective vs prospective comparison and a conglomerate determination of prognostic factors of mortality
thumbnail
Congress Presentation
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources